Infections by Balantidium coli: Complete ICD-11 Coding Guide

1. Introduction

Balantidiasis, caused by the ciliated protozoan Balantidium coli, represents a parasitic intestinal infection that, although less well-known than other protozoan infections, has significant clinical relevance in certain epidemiological contexts. This parasite, considered the largest protozoan capable of infecting humans, measures between 50 to 200 micrometers in length and presents distinctive morphological characteristics that facilitate its microscopic identification.

The clinical importance of Balantidium coli infections lies mainly in its capacity to cause presentations ranging from asymptomatic forms to severe colitis, with intestinal ulcerations that can mimic other inflammatory conditions of the gastrointestinal tract. Transmission occurs primarily through the fecal-oral route, with cysts contaminating water and food, being particularly prevalent in communities with inadequate basic sanitation and in populations that maintain close contact with swine, considered the main natural reservoir of the parasite.

From a public health perspective, balantidiasis remains endemic in various tropical and subtropical regions, affecting especially rural populations and communities with deficient sanitary infrastructure. The infection presents worldwide distribution, however with variable incidence according to local socioeconomic and environmental conditions.

Correct coding of Balantidium coli infections is critical for multiple aspects of healthcare: it enables appropriate epidemiological tracking of this parasitosis, facilitates prevalence and geographic distribution studies, guides public health policies directed at parasitic disease control, ensures appropriate reimbursement in health systems, and enables analysis of clinical outcomes and therapeutic effectiveness. The transition to ICD-11 brought greater specificity in the classification of intestinal protozoan infections, making it essential that healthcare professionals adequately understand the criteria for using code 1A30.

2. Correct ICD-11 Code

Code: 1A30

Description: Infections by Balantidium coli

Parent category: Intestinal infections by protozoa

Official definition: Any condition caused by infection with the protozoan parasite Balantidium coli.

This specific code was designated in ICD-11 to encompass all clinical manifestations resulting from Balantidium coli infection, regardless of severity or symptomatic presentation. The classification recognizes that this ciliated protozoan possesses unique characteristics that justify its separate categorization from other intestinal parasites.

Code 1A30 is part of the chapter on infectious and parasitic diseases, specifically within the grouping of intestinal infections caused by protozoa. This hierarchical location reflects the primarily gastrointestinal nature of the infection, although systemic complications may occasionally occur.

The structure of ICD-11 allows code 1A30 to be used as a principal or secondary diagnosis, depending on the clinical context. When balantidiasis represents the primary condition motivating the visit, it should be coded as the principal diagnosis. In situations where the infection is discovered incidentally during investigation of other conditions, it may be recorded as a secondary diagnosis.

It is important to note that code 1A30 has no official subdivisions in ICD-11, unlike some other categories of infectious diseases. Therefore, all clinical forms of balantidiasis, from asymptomatic carriers to cases of fulminant colitis, are coded with the same base code, with specificities documented in the clinical description of the medical record.

3. When to Use This Code

The code 1A30 should be applied in specific clinical situations where there is confirmation or strong evidence of infection by Balantidium coli. Below, we present detailed practical scenarios:

Scenario 1: Chronic diarrhea with parasitological identification A patient presents with intermittent diarrhea for three months, with episodes of mucopurulent stools. Parasitological examination of stool identifies trophozoites and cysts of Balantidium coli. In this case, code 1A30 is appropriate, as there is laboratory confirmation of the parasite and compatible symptomatology. The presence of blood and mucus in the stool, although nonspecific, is consistent with intestinal mucosal invasion characteristic of symptomatic balantidiasis.

Scenario 2: Ulcerative colitis of parasitic etiology A patient with occupational history of frequent contact with pigs develops severe abdominal pain, tenesmus, and frequent bloody evacuations. Colonoscopy reveals ulcers in the colon, and intestinal biopsy demonstrates trophozoites of Balantidium coli invading the mucosa. Code 1A30 is correct, documenting the specific parasitic etiology of the ulcerative colitis observed. This scenario highlights the importance of histopathological investigation in cases of colitis with relevant epidemiological exposure.

Scenario 3: Asymptomatic carrier detected on screening During epidemiological investigation in a rural community with a diarrhea outbreak, parasitological screening is performed in asymptomatic individuals. A rural worker without symptoms presents with Balantidium coli cysts on stool examination. Even without clinical manifestations, code 1A30 is applicable, as the definition encompasses "any condition caused by infection," including the carrier state. Documentation should specify the absence of symptoms.

Scenario 4: Dysenteric syndrome after travel A patient returns from an endemic area and develops acute dysenteric syndrome with fever, severe abdominal cramps, and more than ten daily evacuations with blood and mucus. Direct fresh stool examination identifies characteristic motile trophozoites of Balantidium coli. Code 1A30 adequately captures this acute presentation, and it is recommended to also document the relationship with recent travel for epidemiological purposes.

Scenario 5: Complication with intestinal perforation A patient with untreated balantidiasis progresses to acute abdomen. Exploratory laparotomy identifies colonic perforation, and anatomopathological examination of the resected segment confirms deep ulcerations with the presence of Balantidium coli. In this case, code 1A30 is used for the parasitic infection, supplemented with an additional code for intestinal perforation, establishing the causal relationship between the parasitosis and the surgical complication.

Scenario 6: Differential diagnosis in immunosuppressed patient An immunosuppressed patient presents with persistent diarrhea. After exclusion of other common causes (cytomegalovirus, cryptosporidiosis, microsporidiosis), serial parasitological examination identifies Balantidium coli. Code 1A30 is appropriate, and may be complemented with a code indicating the state of immunosuppression, recognizing that immunocompromised patients may present with more severe forms of infection.

4. When NOT to Use This Code

It is fundamental to recognize situations where code 1A30 should not be applied, avoiding coding errors that compromise epidemiological records and administrative processes:

Other intestinal protozoal infections with similar presentation: Code 1A30 should not be used when other protozoa are identified as causative agents. Giardiasis (1A31), cryptosporidiosis (1A32), cystoisosporiasis (1A33), and amebiasis (1A36) may present with overlapping symptoms, but require specific codes. Differentiation depends on precise laboratory identification of the parasite, and it is unacceptable to code as balantidiasis based solely on symptoms without parasitological confirmation.

Colitis of other etiologies: Cases of idiopathic ulcerative colitis, Crohn's disease, ischemic colitis, or pseudomembranous colitis caused by Clostridioides difficile should not receive code 1A30, even if they present with similar endoscopic findings. The presence of colonic ulcers is not pathognomonic for balantidiasis, requiring demonstration of the parasite for appropriate coding.

Nonspecific diarrhea without parasitological investigation: Patients with acute or chronic diarrhea without stool parasitological examination should not be coded as 1A30, even in endemic areas or with occupational exposure to swine. Coding requires laboratory confirmation or, at minimum, strong documented clinical-epidemiological evidence.

Mixed infections without specification: When multiple parasites are identified simultaneously, each should receive its specific code. Code 1A30 alone should not be used if Balantidium coli coexists with other protozoa; all identified agents should be coded separately to adequately reflect the complexity of the infection.

Unconfirmed clinical suspicion: Cases where there is only suspicion of balantidiasis, awaiting laboratory confirmation, should not be definitively coded as 1A30. In these cases, symptom coding (diarrhea, nonspecific colitis) is used until the diagnosis is established, at which point the code can be updated.

5. Step-by-Step Coding Process

Step 1: Assess diagnostic criteria

The diagnostic confirmation of balantidiasis is based primarily on parasita identification through specific laboratory methods. Parasitological stool examination constitutes the fundamental diagnostic method, preferably performed on fresh samples where motile trophozoites can be visualized. The characteristic rotatory ciliary movement of trophozoites is highly suggestive when observed under microscopy.

For cases with high clinical suspicion and initial negative parasitological examinations, serial sample collection is recommended, ideally three samples on alternate days, increasing diagnostic sensitivity. Concentration techniques can assist in identifying cysts in asymptomatic carriers or low-intensity infections.

In situations of severe colitis, colonoscopy with biopsy can reveal trophozoites invading the intestinal mucosa, providing definitive diagnosis even when stool examinations are negative. Histopathological examination allows visualization of the parasite in its vegetative form within the tissue, frequently associated with inflammatory reaction and ulceration.

Clinical and epidemiological history complements the investigation, including exposure to pigs, consumption of untreated water, travel to endemic areas, sanitary conditions, and occupation. These elements, although not diagnostic in isolation, increase the pre-test probability and guide laboratory investigation.

Step 2: Verify specifiers

Although code 1A30 does not have formal subdivisions in ICD-11, clinical documentation should include important specifiers that characterize the individual case:

Severity: Document whether the infection is asymptomatic (carrier), mild (occasional diarrhea without systemic compromise), moderate (frequent diarrhea with mild dehydration), or severe (dysenteric syndrome, significant dehydration, complications).

Duration: Specify whether the presentation is acute (less than two weeks), subacute (two to four weeks), or chronic (more than four weeks), information relevant for therapeutic decisions and prognosis.

Complications: Record presence of complications such as severe dehydration, electrolyte imbalances, intestinal perforation, significant gastrointestinal hemorrhage, or secondary sepsis, which may require additional coding.

Immunological status: Identify whether the patient presents with immunosuppression (HIV/AIDS, transplant recipients, use of immunosuppressants, hematologic malignancies), a condition that can influence severity and therapeutic response.

Step 3: Differentiate from other codes

1A31 - Giardiasis: The main difference lies in the etiological agent. Giardia lamblia is a smaller flagellated protozoan, causing predominantly watery diarrhea, abdominal distension, flatulence, and malabsorption, without significant mucosal invasion. Balantidium coli, being ciliated and invasive, frequently causes bloody diarrhea with ulcerations. Microscopic identification is distinctive: Giardia presents a "pear" shape with two nuclei, while Balantidium is large oval with evident cilia.

1A32 - Cryptosporidiosis: Cryptosporidium spp. are much smaller protozoans (4-6 micrometers), causing profuse watery diarrhea especially in immunosuppressed individuals. They do not cause significant ulcerations like Balantidium coli. Diagnosis requires special stains (modified Ziehl-Neelsen) for visualization of oocysts, while Balantidium is easily identified on direct examination. Clinical presentation in immunocompetent individuals tends to be self-limited in cryptosporidiosis, unlike balantidiasis which can persist without treatment.

1A33 - Cystoisosporiasis: Caused by Cystoisospora belli (formerly Isospora belli), it presents characteristic ellipsoid oocysts on special stains. Clinically, it manifests with watery diarrhea, abdominal cramps, and peripheral eosinophilia, being particularly prevalent in patients with AIDS. It differs from balantidiasis by the absence of significant mucosal invasion and by the completely distinct morphology of the parasite.

Step 4: Required documentation

Checklist of mandatory information:

• Parasite identification: method used (direct examination, staining, biopsy), morphological description (trophozoites/cysts), quantity observed
• Symptomatology: type of diarrhea (watery/bloody), evacuation frequency, presence of mucus/blood, abdominal pain, fever, tenesmus
• Duration of symptoms: date of onset, temporal evolution, intermittency
• Epidemiological data: exposure to pigs, water source, sanitary conditions, recent travel, occupation
• Complementary examinations: complete blood count (leukocytosis, eosinophilia), electrolytes, renal function, colonoscopy if performed
• Relevant comorbidities: immunological status, chronic diseases, use of immunosuppressive medications
• Treatment instituted: specific medication, therapeutic response
• Complications: dehydration, need for hospitalization, surgical complications

This complete documentation not only justifies coding with 1A30, but also provides essential information for clinical follow-up, epidemiological analysis, and when necessary, medical audit processes.

6. Complete Practical Example

Clinical Case:

A 42-year-old male patient, a rural worker in a pig farm for 15 years, seeks medical care with a complaint of intermittent diarrhea for two months. He initially reports pasty stools, progressing over the last three weeks to liquid stools with mucus and streaks of blood, occurring 6 to 8 times daily. He associates diffuse abdominal cramping, more intense in the lower abdomen region, worsening after meals. He denies fever but reports unintentional weight loss of approximately 4 kg during this period. He mentions that other farm workers have presented with similar symptoms recently.

On physical examination, the patient is in fair general condition, hydrated, flushed, acyanotic, anicteric. Vital signs: BP 120/75 mmHg, HR 88 bpm, axillary temperature 36.8°C. Abdomen flat, increased bowel sounds, tender on deep palpation in the left iliac fossa and hypogastrium, without signs of peritoneal irritation, without palpable masses or visceromegaly.

Initial laboratory tests were requested: complete blood count revealing leukocytes 9,800/mm³ with mild eosinophilia (6%), hemoglobin 13.2 g/dL, normal platelets. Renal function and electrolytes within normal limits. Parasitological stool examination was requested with collection of three samples on alternate days.

The first parasitological stool examination, performed on a fresh sample, identified the presence of numerous mobile trophozoites, oval, large (approximately 60-80 micrometers), with characteristic rotatory ciliary movement. The morphology was compatible with Balantidium coli, presenting a kidney-shaped macronucleus and cytoplasm with vacuoles. The second sample confirmed the finding, also identifying spherical cysts of the parasite.

Given the persistence of symptoms and presence of bleeding, rectosigmoidoscopy was performed, which revealed colonic mucosa with areas of diffuse hyperemia, edema, and multiple shallow ulcers, some with raised borders, distributed in the sigmoid and descending colon. Biopsies were collected from the ulcer borders.

Histopathological examination of the biopsies demonstrated colonic mucosa with focal ulceration, intense mixed inflammatory infiltrate in the lamina propria, and identification of parasitic structures compatible with Balantidium coli trophozoites invading the epithelium and submucosa, confirming the diagnosis.

Step-by-Step Coding:

Criteria Analysis:

1. Parasitological confirmation: Presence of Balantidium coli trophozoites and cysts identified in multiple stool samples, with characteristic morphology
2. Histopathological confirmation: Demonstration of trophozoites invading intestinal mucosa on biopsy
3. Compatible clinical manifestations: Chronic mucopurulent diarrhea, abdominal cramping, weight loss
4. Consistent endoscopic findings: Ulcerative colitis in a pattern compatible with invasive parasitic infection
5. Relevant epidemiological context: Occupational exposure to pigs, natural reservoir of the parasite

Code chosen: 1A30 - Balantidium coli infections

Complete justification:

Code 1A30 is the appropriate primary code for this case, as all diagnostic criteria for balantidiasis are present. The unequivocal laboratory identification of the parasite in serial parasitological examinations, confirmed by histopathological findings on intestinal biopsy, definitively establishes the diagnosis. The clinical presentation with chronic mucopurulent diarrhea, ulcerative colitis on endoscopy, and parasitic invasion of the mucosa are characteristic of the symptomatic form of Balantidium coli infection.

Prolonged occupational exposure to pigs provides the epidemiological context consistent with parasite transmission, strengthening the diagnosis. The exclusion of other causes of colitis (through clinical history, laboratory tests, and specific agent identification) confirms that Balantidium coli is the etiological agent responsible for the clinical presentation.

Applicable complementary codes:

• Additional code for ulcerative colitis (specifying manifestation of infection)
• Code for weight loss, if documented as a significant manifestation
• Z code for occupational exposure, if relevant for epidemiological recording

Documentation should specify: "Symptomatic balantidiasis with ulcerative colitis confirmed by parasitological and histopathological examination, in a rural worker with occupational exposure to pigs, manifesting as chronic mucopurulent diarrhea for two months."

7. Related Codes and Differentiation

Within the Same Category:

1A31: Giardiasis

When to use vs. 1A30: Use 1A31 when Giardia lamblia (also known as Giardia intestinalis or Giardia duodenalis) is identified as the causative agent. Giardiasis typically presents with watery diarrhea, marked abdominal distension, excessive flatulence, steatorrhea (fatty stools), and symptoms of intestinal malabsorption.

Main difference: Giardia lamblia is a flagellated protozoan that adheres to the small intestine mucosa without causing significant tissue invasion, resulting in watery diarrhea without blood. Balantidium coli is a ciliated protozoan that invades the large intestine mucosa, causing ulcerations and frequently resulting in bloody diarrhea. Microscopically, Giardia presents a characteristic "pear" or "teardrop" shape with two nuclei, while Balantidium is much larger, oval, with evident cilia and a kidney-shaped macronucleus.

1A32: Cryptosporidiosis

When to use vs. 1A30: Apply 1A32 when Cryptosporidium spp. is identified through special stains (modified Ziehl-Neelsen, auramine-rhodamine) or molecular methods. Cryptosporidiosis manifests primarily with profuse watery diarrhea, especially in immunosuppressed patients, and can cause severe dehydration.

Main difference: Cryptosporidium is a very small intracellular protozoan (4-6 micrometers) that infects enterocytes without causing macroscopic ulcerations, resulting in secretory diarrhea. Balantidium coli is extracellular, much larger (50-200 micrometers), deeply invades the mucosa causing endoscopically visible ulcers. Cryptosporidiosis in immunocompetent individuals tends to be self-limited, whereas balantidiasis usually requires specific treatment.

1A33: Cystoisosporiasis

When to use vs. 1A30: Code with 1A33 when Cystoisospora belli is identified, typically through special stains showing characteristic ellipsoid oocysts. Frequently associated with AIDS patients, it presents with chronic watery diarrhea and peripheral eosinophilia.

Main difference: Cystoisospora belli infects epithelial cells of the small intestine, causing villous atrophy without deep invasion or significant ulceration. Balantidium coli invades the colon, causing tissue destruction with ulcerations. Cystoisosporiasis frequently presents with marked eosinophilia (up to 20-30%), an uncommon finding in balantidiasis. Cystoisospora oocysts are ellipsoid and require special staining, whereas Balantidium is easily visualized on direct examination.

Differential Diagnoses:

Amebiasis (1A36): Caused by Entamoeba histolytica, also causes ulcerative colitis with bloody diarrhea. Differentiated by identification of trophozoites with phagocytosed erythrocytes, absence of cilia, and "flask-shaped" ulcer pattern on colonoscopy. Can cause hepatic abscess, a complication not described with Balantidium.

Bacterial colitis: Shigella, Salmonella, Campylobacter, and enteroinvasive E. coli cause bloody diarrhea, but with acute onset, high fever, and positive stool culture. Balantidiasis tends to be subacute or chronic with absent or low-grade fever.

Inflammatory bowel disease: Ulcerative colitis and Crohn's disease can mimic balantidiasis endoscopically, but present with chronic relapsing course, extraintestinal manifestations, and absence of parasites on microscopy.

8. Differences with ICD-10

Equivalent ICD-10 code: A07.0 - Balantidiasis

Main changes in ICD-11:

The transition from ICD-10 to ICD-11 brought significant structural modifications in the classification of intestinal parasitic infections. In ICD-10, balantidiasis was coded as A07.0, located within the grouping A07 (Other intestinal diseases due to protozoa). In ICD-11, it received code 1A30, remaining within the category of intestinal infections due to protozoa, but with reorganized hierarchical structure.

The main conceptual change lies in the more granular approach of ICD-11, which allows better specification of related conditions and facilitates coding of associated complications. While ICD-10 used a more limited alphanumeric system, ICD-11 adopts a structure that allows expansion and greater detail.

Another relevant difference is the digital integration of ICD-11, designed from its conception for use in electronic health systems, with more detailed definitions, expanded indexing terms, and links to complementary clinical terminologies. This facilitates automated coding and reduces ambiguities present in ICD-10.

Practical impact of these changes:

For healthcare professionals, the transition requires familiarization with the new code structure, however the diagnostic logic remains unchanged. The identification of Balantidium coli continues to be the fundamental criterion for coding, regardless of the ICD version used.

In health information systems, migration from ICD-10 to ICD-11 requires adequate mapping of historical codes (A07.0 → 1A30) to maintain continuity in longitudinal epidemiological analyses. Prevalence and incidence studies should consider this transition when comparing data from different periods.

For administrative and reimbursement purposes, the code change may temporarily impact payment systems that have not yet been updated to ICD-11, making it important to verify which version is being used in each specific context during the transition period.

9. Frequently Asked Questions

1. How is balantidiasis diagnosed?

The diagnosis of balantidiasis is based primarily on parasitological examination of feces, where motile trophozoites or cysts of Balantidium coli are identified microscopically. Direct examination of fresh feces is the most sensitive method for detecting trophozoites, which present characteristic ciliary movement easily recognized. Collection of at least three samples on alternate days is recommended, as parasite elimination may be intermittent. In cases of severe colitis, colonoscopy with biopsy can reveal trophozoites invading the intestinal mucosa, being particularly useful when fecal examinations are negative despite strong clinical suspicion. Permanent staining techniques (trichrome, ferric hematoxylin) can aid identification in preserved samples. Molecular methods (PCR) are available in reference centers, offering greater sensitivity, but are not routinely necessary when microscopic examination is adequately performed.

2. Is treatment available in public health systems?

Treatment for balantidiasis uses antiparasitic medications that are generally available in public health systems, although specific availability varies according to region and structure of each system. The traditionally used first-line medication is tetracycline, administered for 10 days, with cure rates exceeding 90%. Alternatives include metronidazole, which also shows good efficacy and is widely available as it is used for multiple parasitic and bacterial conditions. For children and pregnant women, where tetracyclines are contraindicated, metronidazole becomes the preferred option. In situations of resistance or intolerance, iodoquinol can be used. Most of these medications are included in essential medicine lists of international health organizations, favoring their availability in different contexts. Complicated cases may require hospitalization for hydroelectrolytic support and, rarely, surgical intervention in situations of intestinal perforation.

3. How long does treatment last?

Standard treatment for balantidiasis lasts 10 days with tetracycline (500 mg four times daily) or metronidazole (750 mg three times daily). Some protocols use metronidazole for 5 days with satisfactory results, especially in mild cases. Clinical response generally occurs within 3 to 5 days after treatment initiation, with improvement of diarrhea and reduction of abdominal symptoms. Parasitological examination is recommended 2 to 4 weeks after treatment completion to confirm parasite eradication. In cases of treatment failure, which are rare, an additional treatment cycle or medication change may be necessary. Immunosuppressed patients may require prolonged treatment or maintenance therapy, depending on the severity of immunosuppression and initial response. Clinical follow-up should continue for at least 3 months after treatment to detect possible relapses, which may occur in a small proportion of patients.

4. Can this code be used in medical certificates?

Yes, code 1A30 can and should be used in medical certificates when balantidiasis is the condition that justifies absence from activities. Medical documentation should specify the diagnosis clearly, including appropriate coding according to ICD-11. The period of absence depends on the severity of the clinical presentation: mild cases may require few days of rest, while severe forms with significant dehydration or complications may require weeks of absence. It is important that the certificate be accompanied by laboratory documentation confirming the diagnosis (parasitological examination result), strengthening the medical justification. In occupational contexts involving food handling or contact with vulnerable populations, absence may be necessary until parasitological confirmation of cure, protecting third parties from possible transmission. The specific labor legislation of each jurisdiction should be consulted to determine rights and obligations related to absence due to parasitic diseases.

5. Can balantidiasis be transmitted from person to person?

Although theoretically possible, direct person-to-person transmission of balantidiasis is considered rare. The predominant transmission route is fecal-oral through water or food contaminated with parasite cysts. Pigs are the main natural reservoir of Balantidium coli, and most human cases are related to direct or indirect contact with these animals or environments contaminated by their feces. Transmission between humans can occur in situations of poor hygiene, especially in closed institutions, through fecal contamination of water or food. Cysts are the infective form, resisting in the environment for prolonged periods in humid conditions. Asymptomatic carriers may shed cysts in feces, representing a potential source of infection. Adequate personal hygiene measures, including hand washing after toilet use and before handling food, are effective in preventing transmission. In healthcare settings, standard contact precautions are sufficient to prevent nosocomial transmission.

6. What are the possible complications of untreated balantidiasis?

Untreated balantidiasis can progress with various complications, some potentially serious. The most common complication is progressive dehydration resulting from persistent diarrhea, especially problematic in small children and elderly patients. Parasitic invasion of the colonic mucosa can deepen, causing extensive ulcerations that occasionally result in intestinal perforation, a serious complication requiring urgent surgical intervention. Significant lower gastrointestinal hemorrhage can occur when ulcers erode blood vessels in the submucosa, manifesting as voluminous hematochezia. Chronic colitis can lead to progressive malnutrition, especially when associated malabsorption is present. In immunosuppressed patients, infection can disseminate beyond the intestinal tract, with rare reports of hepatic, pulmonary, and genitourinary involvement, although these extraintestinal manifestations are exceptional. Secondary sepsis can occur when intestinal barrier integrity is compromised, allowing bacterial translocation. Fortunately, with timely diagnosis and appropriate treatment, most of these complications can be prevented, and the prognosis is generally excellent.

7. Do people who work with pigs need regular screening?

Although there is no universal consensus on systematic screening, workers with regular occupational exposure to pigs constitute a group at increased risk for balantidiasis and may benefit from targeted surveillance. The decision on implementing screening programs should consider the local prevalence of infection in pig herds, working conditions, available hygiene practices, and health system resources. In areas where infection is endemic in pig herds, annual parasitological examination of workers may be justifiable, especially if there are symptomatic cases in the community. Screening allows identification of asymptomatic carriers who may benefit from treatment, reducing the human reservoir and preventing secondary transmission. More important than universal screening is the implementation of preventive measures: access to drinking water, adequate sanitary facilities, personal protective equipment, occupational hygiene training, and proper management of animal waste. Health education directed at rural workers, emphasizing symptom recognition and importance of seeking early medical care, may be more cost-effective than mass screening in many contexts.

8. How to differentiate balantidiasis from other causes of bloody diarrhea?

Clinical differentiation between balantidiasis and other causes of bloody diarrhea is based on the combination of clinical, epidemiological, and laboratory characteristics. Acute bacterial colitis (Shigella, Salmonella, Campylobacter) typically presents with abrupt onset, high fever, prominent systemic symptoms, and more acute progression, while balantidiasis tends to have subacute or chronic onset. History of exposure to pigs or consumption of untreated water suggests balantidiasis. Amebiasis can present with very similar clinical presentation, differentiated by microscopic identification of Entamoeba histolytica with phagocytosed erythrocytes and possibility of hepatic abscess. Inflammatory bowel disease presents with chronic relapsing course, extraintestinal manifestations, and absence of identifiable infectious agent. Colonoscopy can provide clues: "shirt-button" ulcers suggest amebiasis, pattern of continuous inflammation starting in the rectum suggests ulcerative colitis, while diffuse ulcers in the colon with relatively preserved intermediate mucosa can be seen in balantidiasis. Definitively, parasitological examination of feces with identification of the specific agent establishes the diagnosis, being fundamental to request comprehensive parasite screening, not limited to specific protozoa.

---

Conclusion:

Appropriate coding of Balantidium coli infections using ICD-11 code 1A30 requires clear understanding of diagnostic criteria, clinical manifestations, and differentiation from other intestinal protozooses. This article provided comprehensive guidance for healthcare professionals to correctly apply this code in diverse clinical contexts, contributing to accurate epidemiological records, appropriate case management, and public health surveillance of this parasitosis of significant regional importance.

External References

This article was developed based on reliable scientific sources:

1. 🌍 WHO ICD-11 - Balantidium coli Infections
2. 🔬 PubMed Research on Balantidium coli Infections
3. 🌍 WHO Health Topics
4. 📋 CDC - Centers for Disease Control
5. 📊 Clinical Evidence: Balantidium coli Infections
6. 📋 Ministry of Health - Brazil
7. 📊 Cochrane Systematic Reviews

References verified on 2026-02-04